• 1. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 2. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives N-alkylindoles

Chemical Profile of (1-Methyl-1H-indol-4-yl)methylamine (CAS No. 864264-02-8)

(1-Methyl-1H-indol-4-yl)methylamine is a significant compound in the field of pharmaceutical chemistry, characterized by its complex indole-based structure. This molecule, identified by the CAS number 864264-02-8, has garnered attention due to its potential applications in drug development and medicinal chemistry. The indole moiety, a prominent feature of this compound, is widely recognized for its role in various biological processes and pharmacological activities.

The structural framework of (1-Methyl-1H-indol-4-yl)methylamine consists of a methyl-substituted indole ring connected to an amine group. This configuration suggests possible interactions with biological targets, making it a valuable candidate for further investigation in synthetic chemistry and pharmacology. The presence of the methyl group at the 1-position and the amine functionality at the 4-position enhances the compound's versatility, enabling diverse chemical modifications and functionalizations.

In recent years, there has been a growing interest in indole derivatives due to their broad spectrum of biological activities. Studies have demonstrated that indole-based compounds exhibit properties such as anti-inflammatory, antioxidant, and anticancer effects. The amine group in (1-Methyl-1H-indol-4-yl)methylamine further contributes to its potential as a pharmacophore, facilitating interactions with enzymes and receptors involved in various disease pathways.

One of the most compelling aspects of this compound is its potential role in the development of novel therapeutic agents. Researchers have explored its utility in synthesizing derivatives with enhanced pharmacological properties. For instance, modifications to the indole ring or the amine group can lead to compounds with improved solubility, bioavailability, and target specificity. These advancements underscore the importance of (1-Methyl-1H-indol-4-yl)methylamine as a building block in drug discovery.

The synthesis of (1-Methyl-1H-indol-4-yl)methylamine involves multi-step organic reactions that require precise control over reaction conditions. The indole ring can be synthesized through various methods, including the Bischler-Napieralski reaction or the Fischer indole synthesis. Once the indole core is established, selective functionalization at the 1-position with a methyl group and subsequent introduction of an amine group at the 4-position yield the desired product. These synthetic routes highlight the compound's accessibility for further chemical exploration.

The pharmacological profile of (1-Methyl-1H-indol-4-yl)methylamine has been studied in several preclinical models. Initial investigations suggest that this compound may exhibit inhibitory effects on certain enzymes and receptors relevant to neurological disorders. The indole moiety's ability to modulate neurotransmitter systems makes it a promising candidate for treating conditions such as depression, anxiety, and neurodegenerative diseases. Additionally, its structural similarity to known bioactive molecules suggests potential synergistic effects when combined with other therapeutic agents.

In conclusion, (1-Methyl-1H-indol-4-yl)methylamine (CAS No. 864264-02-8) represents a fascinating compound with significant potential in pharmaceutical research. Its unique structural features and demonstrated biological activities make it a valuable asset for drug development efforts. As research continues to uncover new applications for indole derivatives, compounds like this are likely to play an increasingly important role in addressing unmet medical needs.

• 89455-52-7(9H-Carbazole, 3,5,9-trimethyl-)
• 89455-49-2(9H-Carbazole, 2,5,9-trimethyl-)
• 76089-61-7(9H-Carbazole, 2,4,9-trimethyl-)
• 19293-60-8((1-Methyl-1H-indol-3-yl)methanamine)
• 5621-15-8(1H-Indole, 1,6-dimethyl-)
• 89455-50-5(9H-Carbazole, 2,6,9-trimethyl-)
• 24075-47-6(9H-Carbazole,2,9-dimethyl-)
• 24075-49-8(9H-Carbazole,4,9-dimethyl-)
• 101021-41-4(7H-Dibenzo[c,g]carbazole,5,7,9-trimethyl-)
• 51640-68-7(9H-Carbazole, 4,5,9-trimethyl-)